Home / Stocks / Elantas Beck India Ltd.
ELANTAS

Elantas Beck India Ltd. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹13,881.0

Change

+32.0 (0.23%)

Open

₹13,851.0

Prev. Close

₹13,849.0

Day High

₹14,267.0

Day Low

₹13,761.0

Volume Analysis

Traded

1,128

Delivered

633

Delivery %

56.12%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹14,684.34 ₹14,475.67 ₹14,178.34 ₹13,969.67 ₹13,672.34 ₹13,463.67 ₹13,166.34
Fibonacci ₹14,475.67 ₹14,282.38 ₹14,162.96 ₹13,969.67 ₹13,776.38 ₹13,656.96 ₹13,463.67
Camarilla ₹14,020.15 ₹13,973.77 ₹13,927.38 ₹13,969.67 ₹13,834.62 ₹13,788.23 ₹13,741.85

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-6.17%

1 Month

+20.97%

3 Months

+29.44%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Company Overview

Sector

Chemicals

Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.

TopFund Analysis

Elantas Beck India Ltd. lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 55/100. The strongest factor is Corporate Governance (85/100), while Institutional Ownership (38/100) is the weakest area to weigh before deciding. FII holding has been falling.

TopFund Score — Fundamentals Quality

55/100 — Average

Data confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Corporate Governance

85

Institutional Ownership

38

Risk & Volatility

53

Liquidity

38

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Newspaper Publication - Loss of Share Certificate(s)

Newspaper Publication - Special window for re-lodgement of physical shares transfer request

Newspaper Publication - Unaudited Financial results for the Quarter and Half year ended on 30th June, 2026

Board approved Q1 FY27 results; revenue up 35% to Rs 283.39 crore, net profit Rs 70.86 crore.

Source: BSE regulatory filings, via Screener.in.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 75.0% → 75.0%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 12.54% 12.49% 12.42% 12.43% 12.44% 12.63% 12.78% 12.79% 12.79% 12.75% 12.71% 12.67%
Promoters 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0% 75.0%
FII 0.73% 0.71% 0.7% 0.67% 0.67% 0.67% 0.51% 0.04% 0.04% 0.04% 0.04% 0.05%
DII 11.73% 11.8% 11.88% 11.91% 11.88% 11.71% 11.71% 12.17% 12.17% 12.21% 12.25% 12.28%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Elantas Beck India Ltd. (this stock) — — — —
Solar Industries (i) Ltd 178,673 89.7 28.45 32.6%
Pidilite Industries Ltd 154,533 58.4 14.31 23.9%
Srf Ltd 75,292 33.6 5.36 14.3%
Coromandel Interntl. Ltd 57,480 30.8 4.57 16.4%
Linde India Limited 52,377 95.9 12.28 13.6%
Fact Ltd 51,552 3481.0 37.59 1.61%

Which Mutual Funds Hold Elantas Beck India Ltd.?

Frequently Asked Questions about Elantas Beck India Ltd.

Community Sentiment

What are other investors saying about Elantas Beck India Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.